Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. PTC Therapeutics Inc shares valued at $42,117 were purchased by Golden Lee Scott on Apr 02 ’25. At $46.95 per share, Golden Lee Scott acquired 897 shares.
Also, Pauwels Eric sold 6,762 shares, netting a total of over 384,067 in proceeds. Following the sale of shares at $56.80 each, the insider now holds 72,640 shares.
Before that, Pauwels Eric had sold 4,458 shares from its account. In a trade valued at $246,037, the CHIEF BUSINESS OFFICER traded PTC Therapeutics Inc shares for $55.19 each. Upon closing the transaction, the insider’s holdings decreased to 4,458 shares, worth approximately $3.84 million.
As published in a research note from BofA Securities on March 11, 2025, PTC Therapeutics Inc [PTCT] has been rated up from an Underperform to a Neutral and the price target has been revised to $55 from $41. Analysts at Scotiabank started covering the stock with ‘”a Sector perform”‘ outlook in a report released in early March. As of December 13, 2024, Morgan Stanley has increased its “an Equal-weight” rating to a “an Overweight” for PTCT. Earlier on December 03, 2024, RBC Capital Mkts upgraded its rating. Their new recommendation was “an Outperform” for PTCT stock which previously was a “a Sector perform”.
Analyzing PTCT Stock Performance
During the last five days, there has been a drop of approximately -12.55%. Over the course of the year, PTC Therapeutics Inc shares have jumped approximately 7.16%. Shares of the company reached a 52-week high of $58.38 on 03/17/25 and a 52-week low of $41.67 on 01/14/25. A 50-day SMA is recorded $51.14, while a 200-day SMA reached $41.59.
Support And Resistance Levels for PTC Therapeutics Inc (PTCT)
According to the 24-hour chart, there is a support level at 46.22, which, if violated, would cause prices to drop to 44.08. In the upper region, resistance lies at 49.73. The next price resistance is at 51.10. RSI (Relative Strength Index) is 37.67 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -5.76, which suggests the price will decrease in the coming days. Percent R is at 77.12%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
